BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22869031)

  • 1. Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain.
    Steele JW; Ju S; Lachenmayer ML; Liken J; Stock A; Kim SH; Delgado LM; Alfaro IE; Bernales S; Verdile G; Bharadwaj P; Gupta V; Barr R; Friss A; Dolios G; Wang R; Ringe D; Protter AA; Martins RN; Ehrlich ME; Yue Z; Petsko GA; Gandy S
    Mol Psychiatry; 2013 Aug; 18(8):882-8. PubMed ID: 22869031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model.
    Steele JW; Lachenmayer ML; Ju S; Stock A; Liken J; Kim SH; Delgado LM; Alfaro IE; Bernales S; Verdile G; Bharadwaj P; Gupta V; Barr R; Friss A; Dolios G; Wang R; Ringe D; Fraser P; Westaway D; St George-Hyslop PH; Szabo P; Relkin NR; Buxbaum JD; Glabe CG; Protter AA; Martins RN; Ehrlich ME; Petsko GA; Yue Z; Gandy S
    Mol Psychiatry; 2013 Aug; 18(8):889-97. PubMed ID: 22850627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latrepirdine (Dimebon®), a potential Alzheimer therapeutic, regulates autophagy and neuropathology in an Alzheimer mouse model.
    Steele JW; Gandy S
    Autophagy; 2013 Apr; 9(4):617-8. PubMed ID: 23380933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latrepirdine (dimebon) enhances autophagy and reduces intracellular GFP-Aβ42 levels in yeast.
    Bharadwaj PR; Verdile G; Barr RK; Gupta V; Steele JW; Lachenmayer ML; Yue Z; Ehrlich ME; Petsko G; Ju S; Ringe D; Sankovich SE; Caine JM; Macreadie IG; Gandy S; Martins RN
    J Alzheimers Dis; 2012; 32(4):949-67. PubMed ID: 22903131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
    Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer's and other neurodegenerative diseases.
    Bharadwaj PR; Bates KA; Porter T; Teimouri E; Perry G; Steele JW; Gandy S; Groth D; Martins RN; Verdile G
    Transl Psychiatry; 2013 Dec; 3(12):e332. PubMed ID: 24301650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
    Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH
    Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel autophagy modulator 6-Bio ameliorates SNCA/α-synuclein toxicity.
    Suresh SN; Chavalmane AK; Dj V; Yarreiphang H; Rai S; Paul A; Clement JP; Alladi PA; Manjithaya R
    Autophagy; 2017 Jul; 13(7):1221-1234. PubMed ID: 28350199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Sites of Neuroprotective Action of Dimebon (Latrepirdine).
    Ustyugov A; Shevtsova E; Bachurin S
    Mol Neurobiol; 2015 Oct; 52(2):970-8. PubMed ID: 26123670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginkgolic acid promotes autophagy-dependent clearance of intracellular alpha-synuclein aggregates.
    Vijayakumaran S; Nakamura Y; Henley JM; Pountney DL
    Mol Cell Neurosci; 2019 Dec; 101():103416. PubMed ID: 31654699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diterpene glycosides from Holothuria scabra exert the α-synuclein degradation and neuroprotection against α-synuclein-Mediated neurodegeneration in C. elegans model.
    Chalorak P; Sornkaew N; Manohong P; Niamnont N; Malaiwong N; Limboonreung T; Sobhon P; Aschner M; Meemon K
    J Ethnopharmacol; 2021 Oct; 279():114347. PubMed ID: 34147616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequestration of synaptic proteins by alpha-synuclein aggregates leading to neurotoxicity is inhibited by small peptide.
    Choi MG; Kim MJ; Kim DG; Yu R; Jang YN; Oh WJ
    PLoS One; 2018; 13(4):e0195339. PubMed ID: 29608598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease.
    Grassi D; Howard S; Zhou M; Diaz-Perez N; Urban NT; Guerrero-Given D; Kamasawa N; Volpicelli-Daley LA; LoGrasso P; Lasmézas CI
    Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2634-E2643. PubMed ID: 29487216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-Synuclein-derived peptides with neuroprotective activity: an alternative treatment of neurodegenerative disorders?
    Windisch M; Hutter-Paier B; Schreiner E; Wronski R
    J Mol Neurosci; 2004; 24(1):155-65. PubMed ID: 15314265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct alpha-Synuclein species induced by seeding are selectively cleared by the Lysosome or the Proteasome in neuronally differentiated SH-SY5Y cells.
    Pantazopoulou M; Brembati V; Kanellidi A; Bousset L; Melki R; Stefanis L
    J Neurochem; 2021 Mar; 156(6):880-896. PubMed ID: 32869336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracts from two ubiquitous Mediterranean plants ameliorate cellular and animal models of neurodegenerative proteinopathies.
    Briffa M; Ghio S; Neuner J; Gauci AJ; Cacciottolo R; Marchal C; Caruana M; Cullin C; Vassallo N; Cauchi RJ
    Neurosci Lett; 2017 Jan; 638():12-20. PubMed ID: 27919712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods.
    Tarutani A; Arai T; Murayama S; Hisanaga SI; Hasegawa M
    Acta Neuropathol Commun; 2018 Apr; 6(1):29. PubMed ID: 29669601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?
    Fujita M; Sekigawa A; Sekiyama K; Sugama S; Hashimoto M
    J Neurol; 2009 Aug; 256 Suppl 3():286-92. PubMed ID: 19711118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maysin plays a protective role against α-Synuclein oligomers cytotoxicity by triggering autophagy activation.
    Leri M; Vasarri M; Palazzi L; Barletta E; Nielsen E; Bucciantini M; Degl'Innocenti D
    Food Chem Toxicol; 2020 Oct; 144():111626. PubMed ID: 32738375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.